1. Home
  2. BIIB vs TTWO Comparison

BIIB vs TTWO Comparison

Compare BIIB & TTWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biogen Inc.

BIIB

Biogen Inc.

HOLD

Current Price

$174.28

Market Cap

24.2B

Sector

Health Care

ML Signal

HOLD

Logo Take-Two Interactive Software Inc.

TTWO

Take-Two Interactive Software Inc.

HOLD

Current Price

$241.87

Market Cap

43.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIIB
TTWO
Founded
1978
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
24.2B
43.2B
IPO Year
1991
1997

Fundamental Metrics

Financial Performance
Metric
BIIB
TTWO
Price
$174.28
$241.87
Analyst Decision
Buy
Strong Buy
Analyst Count
22
20
Target Price
$177.40
$269.25
AVG Volume (30 Days)
2.0M
1.4M
Earning Date
10-30-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
10.97
N/A
Revenue
$10,065,900,000.00
$6,219,900,000.00
Revenue This Year
$3.61
$17.42
Revenue Next Year
N/A
$38.29
P/E Ratio
$15.86
N/A
Revenue Growth
4.77
13.98
52 Week Low
$110.04
$177.35
52 Week High
$185.17
$264.79

Technical Indicators

Market Signals
Indicator
BIIB
TTWO
Relative Strength Index (RSI) 55.41 44.69
Support Level $169.24 $245.99
Resistance Level $180.79 $250.18
Average True Range (ATR) 5.36 4.16
MACD -1.56 0.27
Stochastic Oscillator 33.70 41.34

Price Performance

Historical Comparison
BIIB
TTWO

About BIIB Biogen Inc.

Biogen is an established biopharmaceutical company focused on treatments for neurological diseases and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 45% of total revenue in 2024. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (18% of total in 2024), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).

About TTWO Take-Two Interactive Software Inc.

Take-Two is one of the largest global developers and publishers of video games, with labels including Rockstar, 2K, and Zynga. Grand Theft Auto is the firm's biggest franchise, accounting for about 30% of total sales for the past decade. NBA 2K is the industry's dominant basketball video game, with Take-Two releasing a new version annually. Other notable franchises include Red Dead Redemption, Borderlands, and Civilization. Typically, more than three-fourths of the firm's sales are from in-game spending, with the remainder coming from initial game sales. Since acquiring Zynga in 2022, mobile makes up about half of total sales.

Share on Social Networks: